Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Pharmacy Innovations

Pharmacy Innovations Recalls

All product recalls associated with Pharmacy Innovations.

Get alerts for this brand

Recall Summary

Total Recalls

266

Past Year

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 41–60 of 266 recalls

NADH Injectable (Pharmacy Innovations) – sterility concerns (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Glycerin Injectable (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Mitomycin Ophthalmic Solution (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class II

1 234 5...14

Page 3 of 14Next

Moderate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Semaglutide Injection (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Flurbiprofen (Pharmacy Innovations) – Sterility Risk (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

BSS Plus/Lidocaine Opth (Pharmacy Innovations) – Sterility Risk (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Testosterone Ophth Ointment (Pharmacy Innovations) - sterility risk (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

PE1/Papaverine Combination Injectable (Pharmacy Innovations) – sterility concerns (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Atropine Sulfate Dropper (Pharmacy Innovations) – sterility concerns (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Magnesium Chloride (Pharmacy Innovations) – Sterility Risk (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

5-Fluorouracil (Pharmacy Innovations) – Sterility Risk (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Minoxidil Injectable (Pharmacy Innovations) - sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Mitomycin Ophthalmic Solution (Pharmacy Innovations) – sterility concerns (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Voriconazole Ophthalmic Solution (Pharmacy Innovations) – sterility concerns (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Methylcobalamin Injection (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Gentamicin Bladder Irrigation (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

PE1/PAPAV/PHEN Injection (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Progesterone Injectable (Pharmacy Innovations) – sterility concerns (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Estradiol/Testosterone Injectable (Pharmacy Innovations) – sterility concerns (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Hydroxocobalamin (Pharmacy Innovations) – Sterility Risk (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations